General Information of the Compound
Compound ID
CP0946067
Compound Name
4-((5-(1H-benzo[d]imidazol-2-ylthio)furan-2-yl)methyl)morpholine
    Show/Hide
Structure
Formula
C16H17N3O2S
Molecular Weight
315.398
Canonical SMILES
c1ccc2[nH]c(Sc3ccc(CN4CCOCC4)o3)nc2c1
    Show/Hide
InChI
InChI=1S/C16H17N3O2S/c1-2-4-14-13(3-1)17-16(18-14)22-15-6-5-12(21-15)11-19-7-9-20-10-8-19/h1-6H,7-11H2,(H,17,18)
    Show/Hide
InChIKey
NRPGNMSRLSNHEG-UHFFFAOYSA-N
Physicochemical Property
logP
3.1393
Rotatable Bonds
4
Heavy Atom Count
22
Polar Areas
54.29
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 121395551
ChEMBL ID
CHEMBL4445261
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04664, Myc proto-oncogene protein
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 32900 nM
   TI
   LI
   LO
   TS